A clinically relevant benefit of statins in young patients with systemic lupus erythematosus cannot be excluded: Comment on the article by Schanberg et al

Arthritis and Rheumatism

Volumn 64, Issue 8, 2012, Pages 2805-

  Steichen, Olivier ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; PLACEBO;

ADOLESCENT DISEASE; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CHILDHOOD DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; LETTER; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; FEMALE; HEPTANOIC ACIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PYRROLES;

EID: 84864451092     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34521     Document Type: Letter

References (0)